Publications

5808 Results

Extended oral etopside (E) and oral cyclophosphamide (C) for lung cancer

Authors
SM Grunberg;J Crowley;R Livingston
Journal / Conference
Lung Cancer 11(Suppl.1):121(#464)
Year
1994
Research Committee(s)
Lung
Study Number(s)
SWOG-9038, SWOG-9307

Treatment of histologically confirmed D2 prostate cancer - a comparison of bilateral orchiectomy with or without flutamide (intergroup study 0105)

Authors
ED Crawford;MA Eisenberger;B Blumenstein;DG McLeod;DJ Culkin;AJ Bueschen;IM Thompson;BA Lowe
Journal / Conference
Urology 151(5):238A(#44)
Year
1994
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8894 (INT-0105) (EST-2889)

Randomized trial of vitamin A versus observation as adjuvant therapy in high risk primary malignant melanoma: A Southwest Oncology Group study

Authors
FL Meyskens;PY Liu;RJ Tuthill;VK Sondak;WS Fletcher;WR Jewell;W Samlowski;SP Balcerzak;DJ Rector;RD Noyes;JJ Costanzi
Journal / Conference
Journal of Clinical Oncology 12(10):2060-2065
Year
1994
Research Committee(s)
Melanoma
Study Number(s)
SWOG-8049

Phase II evaluation of merbarone in renal cell carcinoma

Authors
RC Flanigan;JH Saiers;M Wolf;EH Kraut;AY Smith;B Blumenstein;ED Crawford
Journal / Conference
Investigational New Drugs 12(2):147-149
Year
1994
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8929

A phaseIII randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma: A Southwest Oncology Group study

Authors
WS Dalton;JJ Crowley;SE Salmon;TM Grogan;LR Laufman;GR Weiss;JD Bonnet
Journal / Conference
Cancer 75(3):815-820
Year
1994
Research Committee(s)
Myeloma
Study Number(s)
SWOG-8900

Phase II trial of trimetrexate in untreated advanced gastric carcinoma. A Southwest Oncology Group study.

Authors
A Hantel;C Tangen;JS Macdonald;SP Richman;RP Pugh;T Pollock
Journal / Conference
Investigational New Drugs 12:155-157
Year
1994
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8623

Comparison of patient characteristics and outcome between a single institution and cooperative group phase II trial in metastatic melanoma with identical eligibility

Authors
L Flaherty;M Hussein;PY Liu;D Smith;V Sondak
Journal / Conference
ASCO 13:397(#1352)
Year
1994
Research Committee(s)
Melanoma
Study Number(s)
SWOG-8921

HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: A previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3

Authors
AA Scott;DR Head;KJ Kopecky;FR Appelbaum;KS Theil;MR Grever;I-M Chen;MH Whittaker;BB Griffith;JD Licht;S Waxman;MM Whalen;AD Bankhurst;LC Richter;TM Grogan;CL Willman
Journal / Conference
Blood 84(1):244-255
Year
1994
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600, SWOG-8750, SWOG-8828, SWOG-9007, SWOG-9031

Recruitment with high physiological doses of estradiol preceding chemotherapy: Flow cytometric and therapeutic results in women with locally advanced breast cancer-A Southwest Oncology Group study.

Authors
CJ Fabian;BF Kimler;R McKittrick;CH Park;F Lin;L Krishnan;WR Jewell;CK Osborne;S Martino;LF Hutchins;LA Leong;S Green
Journal / Conference
Cancer Research 54:5357-5362
Year
1994
Research Committee(s)
Breast
Study Number(s)
SWOG-8568

Phase II trial of fazarabine (FAZ) in advanced non-small cell carcinoma of the lung (NSCLC) - a clinical trial report and cost analysis: A Southwest Oncology Group study

Authors
SK Williamson;JJ Crowley;JW Goodwin;RB Livingston
Journal / Conference
ASCO 13:347#(1160)
Year
1994
Research Committee(s)
Lung
Study Number(s)
SWOG-9138